you are here:

Glenmark Pharma Ltd.

BSE: 532296 | NSE: GLENMARK |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE935A01035 | SECTOR: Pharmaceuticals

BSE Live

Dec 01, 16:00
476.70 5.50 (1.17%)
Volume
AVERAGE VOLUME
5-Day
126,938
10-Day
102,186
30-Day
110,622
72,972
  • Prev. Close

    471.20

  • Open Price

    475.00

473.65

Today’s L/H

480.55
168.00

52 Wk L/H

572.70
424.10

L/U Price Band

518.30
  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

  •  VWAP

    477.03
     Beta
    0.66
  • Market Depth (01 Dec 2020)

    BUYSELL
    QTY PRICE PRICE QTY
    970 477.00 477.30 50
    11 476.90 477.35 493
    493 476.60 477.50 1184
    25 476.50 477.55 1951
    397 476.45 477.85 1896
    0 Total Total 0
     Market Depth
    BUY 0
    SELL 0
    0%
    0%

NSE Live

Dec 01, 15:59
477.10 5.70 (1.21%)
Volume
AVERAGE VOLUME
5-Day
2,331,184
10-Day
1,791,223
30-Day
2,604,252
2,185,660
  • Prev. Close

    471.40

  • Open Price

    474.60

473.10

Today’s L/H

480.90
161.65

52 Wk L/H

573.05
424.30

L/U Price Band

518.50
  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    477.10 (1485)

  •  VWAP

    476.97
     Beta
    0.80
  • DELIVERY AVERAGES
    3-Day
    30.63%
    5-Day
    25.70%
    8-Day
    24.93%
    Deliverables
  • SMA
    30
    50
    150
    200
    SMA
Powered by Trendlyne
Parameters
NSE
BSE
Bid Price
0.00
0.00
Bid Qty
0
0
Offer Price
477.10
0.00
Offer Qty
1485
0
Today's Low
473.10
473.65
Today's High
480.90
480.55
52 Wk Low
161.65
168.00
52 Wk High
573.05
572.70
Open Price
474.60
475.00
Prev. Close
471.40
471.20
Expiry Date
479.95 5.75 ( 1.21 % )
Parameters
NSE
Open Price
478.00
High Price
483.80
Low Price
473.95
Prev. Close
474.20
Average Price
479.12
No. of Contracts Traded
2,393
Turnover (Rs. In Lakhs)
13,185.14
Market Lot
1150
Open Interest
5,158,900
Open Interest Change
16,100
Open Interest Change %
0.31
Expiry Date
Option Type
Strike Price
479.95 5.75 ( 1.21 % )
Parameters
NSE
Open Price
478.00
High Price
483.80
Low Price
473.95
Prev. Close
474.20
Average Price
479.12
No. of Contracts Traded
2,393
Turnover (Rs. In Lakhs)
13,185.14
Market Lot
1150
Open Interest
5,158,900
Open Interest Change
16,100
Open Interest Change %
0.31

Charts

  • Open : -
  • High : -
  • Low -
  • Close: -
  • Volume -

TECHNICAL ANALYSIS

TECHNICAL RATING
Neutral
Moving Averages Neutral
Technical Indicators Neutral
Moving Averages Crossovers Neutral
Pivot levels
Type R1 R2 R3 PP S1 S2 S3
Classic 476.80 482.20 485.60 473.40 468.00 464.60 459.20
Fibonacci 476.76 478.84 482.20 473.40 470.04 467.96 464.60
Camarilla 472.21 473.01 473.82 473.40 470.59 469.79 468.98

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

SIMPLE MOVING AVERAGES
Days NSE
5 472.84
10 477.86
20 483.63
50 483.16
100 472.23
200 400.89
Pivot levels

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

Pivot levels

Type R1 R2 R3 PP S1 S2 S3
Classic 487.07 502.73 516.07 473.73 458.07 444.73 429.07
Fibonacci 484.81 491.66 502.73 473.73 462.66 455.81 444.73
Camarilla 474.06 476.72 479.38 473.73 468.74 466.08 463.42

Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

SIMPLE MOVING AVERAGES
Pivot levels

Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

Pivot levels
Type R1 R2 R3 PP S1 S2 S3
Classic 504.57 537.73 559.82 482.48 449.32 427.23 394.07
Fibonacci 503.59 516.63 537.73 482.48 461.38 448.34 427.23
Camarilla 476.46 481.53 486.59 482.48 466.34 461.27 456.21

Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

SIMPLE MOVING AVERAGES
Pivot levels

Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

Valuation

    • Market Cap (Rs Cr.)
      13,450.96
    • P/E
      8.63
    • Book Value (Rs)
      468.74
    • Dividend (%)
      250.00
    • Market Lot
      1
    • Industry P/E
      37.76
    • EPS (TTM)
      55.29
    • P/C
      7.93
    • Price/Book
      1.02
    • Dividend Yield.(%)
      0.52
    • Face Value (RS)
      1.00
    • Deliverables (%)
      DELIVERY AVERAGES (%)
      3-Day
      30.63
      5-Day
      25.70
      8-Day
      24.93
      31.55

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

    • Market Cap (Rs Cr.)
      13,450.96
    • P/E
      14.97
    • Book Value (Rs)
      215.12
    • Dividend (%)
      250.00
    • Market Lot
      1
    • Industry P/E
      37.76
    • EPS (TTM)
      31.87
    • P/C
      10.22
    • Price/Book
      2.22
    • Dividend Yield.(%)
      0.52
    • Face Value (RS)
      1.00
    • Deliverables (%)
      DELIVERY AVERAGES (%)
      3-Day
      30.63
      5-Day
      25.70
      8-Day
      24.93
      31.55

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

F&O QUOTE

NSE 479.95 5.75 (1.21%)
Instrument Type
Expiry Date
Option Type
Strike Price
    • Open Price
      478.00
    • High Price
      483.80
    • Low Price
      473.95
    • Prev. Close
      474.20
    • Average Price
      479.12
    • No. of Contracts Traded
      2,393
    • Turnover (Rs. In Lakhs)
      13,185.14
    • Market Lot
      1150

Forum

Community Sentiments

  • 94% BUY
  • 3% SELL
  • 3% HOLD
94%
of moneycontrol users recommend buying Glenmark

What's your call on Glenmark today?

Read 24 investor views

BUY SELL HOLD

Action in Glenmark Pharma Ltd.

Pre-Opening Session Prices9:00 am - 9:15 am

BSE

Dec 01, 09:15
475.00 3.80 (0.81%)
High 475.00
Low 471.45
Prev. Close 471.20

NSE

Dec 01, 09:15
474.60 3.20 (0.68%)
High 474.60
Low 471.10
Prev. Close 471.40

Financials

(Rs. Cr)
Quarterly JUN 2020 MAR 2020 DEC 2019 SEP 2019 JUN 2019
Sales
2,344 2,767 2,735 2,815 2,322
Other Income
58 44 32 80 1
Total Income
2,403 2,811 2,768 2,895 2,324
Total Expenditure
1,951 2,395 2,401 2,458 2,071
EBIT
451 416 367 437 252
Interest
93 98 96 89 93
Tax
103 97 80 91 50
Net Profit
254 220 190 255 109

Historical Prices

On
Current Price %Gain / Loss
Open Price 348.00 475.00
36.49
High Price 358.00 480.55
34.23
Low Price 343.75 473.65
37.79
Close Price 346.25 471.20
36.09
Volume 237,248 72,972
-69.24
On
Current Price %Gain / Loss
Open Price 343.55 474.60
38.15
High Price 358.00 480.90
34.33
Low Price 343.20 473.10
37.85
Close Price 346.55 471.40
36.03
Volume 7,373,413 2,185,660
-70.36
Click Here to view the Open, High, Low, Close, Volume and Historic data for
Index Price Change %Chg
NIFTY 50 13109.00 140.00 1.08
SENSEX 44655.44 505.72 1.15
NIFTY BANK 29817.80 208.75 0.71
NIFTY IT 22170.90 406.00 1.87
S&P BSE Smallcap 17013.04 137.89 0.82
Index Price Change %Chg
CAC (Dec 01) 5,574.59 56.04 1.02
DAX (Dec 01) 13,410.88 119.72 0.90
FTSE (Dec 01) 6,385.04 118.85 1.90
Straits Times (Dec 01) 2,814.12 8.17 0.29
SGX Nifty (Dec 01) 13,155.50 4.50 0.03

CORPORATE ACTION

Date Agenda
Nov 06, 2020 Quarterly Results
Aug 14, 2020 Quarterly Results
Jun 26, 2020 Audited Results & Dividend
Feb 14, 2020 Quarterly Results & Others
Type Dividend% Ex-Dividend date
Final 250.00 Sep 17, 2020
Final 200.00 Sep 19, 2019
Final 200.00 Sep 19, 2018
Final 200.00 Sep 20, 2017
Final 200.00 Aug 03, 2016
Ratio Announcement Date Ex-Bonus
1:1 Jan 06, 2005 Mar 04, 2005
Old FV New FV Ex-Split
2 1 Sep 10, 2007
10 2 Oct 23, 2003
Ratio Premium Ex-Bonus
No Rights Information is available for Glenmark Pharma
Date Agenda
Sep 29, 2020 -
Sep 27, 2019 -
Sep 27, 2018 -
Sep 28, 2018 -
Sep 29, 2017 -

Dividend Summary

For the year ending March 2020 Glenmark Pharma has declared an equity dividend of 250.00% amounting to Rs 2.5 per share. At the current share price of Rs 477.10 this results in a dividend yield of 0.52%.

The company has a good dividend track report and has consistently declared dividends for the last 5 years.

SHARE HOLDING PATTERN & MUTUAL FUND HOLDING

Share Holding Pattern in (%)

Standalone September 2020 June 2020 March 2020 December 2019
Promoters 46.63 46.62 46.62 46.59
Pledged 0 0 0 0
FII/FPI 25.79 23.4 28.51 30.16
Total DII 12.19 13.38 11.8 11.72
Fin.Insts 0.83 3.16 2.99 2.97
Insurance Co 0 0 0 0
MF 3.56 2.36 3.74 4.07
Others DIIs 7.8 7.86 5.07 4.68
Others 15.4 16.59 13.06 11.53
Total 100.01 99.99 99.99 100

PEERS COMPARISON

Company Name Last Price % Change 52 Wk High 52 Wk Low Market Cap Sales Qtr Net Profit Qtr
Glenmark 476.70 1.17 572.70 168.00 13450.96 6,712.63 1,354.55
Sun Pharma 539.75 5.51 564.90 315.20 129504.11 12,531.93 3,211.14
Divis Labs 3615.00 0.21 3760.00 1632.70 95966.89 5,310.57 1,372.71
Dr Reddys Labs 4833.50 0.08 5514.65 2497.60 80373.85 11,850.40 2,937.70
Cipla 755.55 1.46 829.00 356.75 60931.04 12,659.15 2,318.17

COMPANY OVERVIEW

Glenmark Pharmaceuticals Ltd has a significant presence in the branded generics markets across emerging economies including India.The company entered into the dermatology market through the launch of its Candid Cream.Glenmarks ground-breaking drug discovery effort is primarily focused in the areas of inflammation [asthma/COPD, rheumatoid arthritis etc.], metabolic disorders [diabetes, obesity, etc.] and pain [neuropathic pain and inflammatory pain].The formulations business of the company focuses on therapeutic areas viz. dermatology, anti-infective, respiratory, cardiac, diabetes, gynecology, CNS, and oncology. India is the largest market in terms of revenue for the organization.

COMPANY INFORMATION

  • Registered Office

  • Registrars

    • Name

      Karvy Computershare Private Ltd.

    • Address

      Plot no. 31-32, GachibowliFinancial DistrictNanakramguda

    • City

      Hyderabad 500032

    • State

      Telangana

    • Tel. No.

      040-23001153

    • Fax No.

    • Email

    • Internet

  • Management

    • Name

      Designation

    • Glenn Saldanha

      Chairman & Managing Director

    • Cherylann Pinto

      Executive Director - Corporate Affairs

    • V S Mani

      Executive Director & Global CFO

    • Rajesh V Desai

      Non Executive Director

    • Brian W Tempest

      Non Executive Director

  • Listing

    Whether The Company Forms A Part Of The Following Indices -
    • Sensex

      No

    • Nifty

      No

    • Bse-100

      Yes

    • Bse-200

      Yes

    • S&P CNX 500

      Yes

    • CNX Midcap

      Yes

About Glenmark Pharma Ltd.

Glenmark is in the Pharmaceuticals sector.

It is listed on the BSE with a BSE Code of 532296 and the NSE with an NSE Code of GLENMARK.

Related Searches